Warning: The NCBI web site requires JavaScript to function. more...
Optimal assignment methods for ligand-based virtual screening.
Jahn A, Hinselmann G, Fechner N, Zell A.
J Cheminform. 2009 Aug 25;1:14.
Related citations
NMR-based screening methods for lead discovery.
Vogtherr M, Fiebig K.
EXS. 2003;(93):183-202. Review.
Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring.
Zhang Q, Muegge I.
J Med Chem. 2006 Mar 9;49(5):1536-48.
Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors.
Krüger DM, Evers A.
ChemMedChem. 2010 Jan;5(1):148-58.
Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity.
Quintus F, Sperandio O, Grynberg J, Petitjean M, Tuffery P.
BMC Bioinformatics. 2009 Aug 11;10:245.
LASSO-ligand activity by surface similarity order: a new tool for ligand based virtual screening.
Reid D, Sadjad BS, Zsoldos Z, Simon A.
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):479-87. Epub 2008 Jan 18.
Virtual screening: an effective tool for lead structure discovery?
Langer T, Hoffmann RD.
Curr Pharm Des. 2001 May;7(7):509-27. Review.
Structure-based drug screening and ligand-based drug screening with machine learning.
Fukunishi Y.
Comb Chem High Throughput Screen. 2009 May;12(4):397-408. Review.
The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data.
Harper G, Bravi GS, Pickett SD, Hussain J, Green DV.
J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):2145-56.
Ligand docking and structure-based virtual screening in drug discovery.
Cavasotto CN, Orry AJ.
Curr Top Med Chem. 2007;7(10):1006-14. Review.
Free resources to assist structure-based virtual ligand screening experiments.
Villoutreix BO, Renault N, Lagorce D, Sperandio O, Montes M, Miteva MA.
Curr Protein Pept Sci. 2007 Aug;8(4):381-411. Review.
Use of reduced graphs to encode bioisosterism for similarity-based virtual screening.
Birchall K, Gillet VJ, Willett P, Ducrot P, Luttmann C.
J Chem Inf Model. 2009 Jun;49(6):1330-46.
Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques.
Ebalunode JO, Ouyang Z, Liang J, Zheng W.
J Chem Inf Model. 2008 Apr;48(4):889-901. Epub 2008 Apr 9.
Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets.
Chen Z, Li HL, Zhang QJ, Bao XG, Yu KQ, Luo XM, Zhu WL, Jiang HL.
Acta Pharmacol Sin. 2009 Dec;30(12):1694-708. Epub 2009 Nov 23.
New methodologies for ligand-based virtual screening.
Stahura FL, Bajorath J.
Curr Pharm Des. 2005;11(9):1189-202. Review.
Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.
Ma XH, Jia J, Zhu F, Xue Y, Li ZR, Chen YZ.
Comb Chem High Throughput Screen. 2009 May;12(4):344-57. Review.
Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios.
Hristozov DP, Oprea TI, Gasteiger J.
J Comput Aided Mol Des. 2007 Oct-Nov;21(10-11):617-40. Epub 2007 Nov 16.
Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A, Hessler G, Matter H, Klabunde T.
J Med Chem. 2005 Aug 25;48(17):5448-65.
Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN, Abagyan RA.
J Mol Biol. 2004 Mar 12;337(1):209-25.
Unconventional 2D shape similarity method affords comparable enrichment as a 3D shape method in virtual screening experiments.
Ebalunode JO, Zheng W.
J Chem Inf Model. 2009 Jun;49(6):1313-20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on